Skip to main content

Table 5 Multivariate analysis of the inflammation-based cumulative prognostic score (ICPS) and IPI score

From: An inflammation-based cumulative prognostic score system in patients with diffuse large B cell lymphoma in rituximab era

Characteristic OS PFS
P-value HR (95% Cl) P-value HR (95% Cl)
IPI (Hi, H) <0.001 2.697 (1.652–4.405) 0.001 1.892(1.293–1.767)
ICPS ≥ 2 <0.001 3.044 (1.929–4.804) <0.001 2.293(1.577–3.335)
  1. Abbreviations: OS Overall survival, PFS Progression-free survival, HR Hazard Ratio, 95% Cl, 95% confidence limits, IPI International Prognostic Index, Hi High-intermediate, H High, ICPS Inflammation-based cumulative prognostic score